An observational study in Psoriasis, sponsored by AbbVie. Completed at 15 sites in Italy. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2024-10-26.
Sponsored by AbbVie · Observational
Psoriasis, is an inflammatory chronic skin disease which has a heavy physical and psychosocial impact on participant's life. This is a study to finalize and validate a questionnaire to assess the long-term effect of long-term psoriasis in adult participants.
Approximately 550 adult participants with moderate to severe plaque psoriasis will be enrolled in approximately 15 dermatology centers in Italy.
Participants will receive standard of care while participating in this study. No drug will be administered as a part of this study. The duration of this study is up to 22 months.
There is no additional burden for participants in this study. Participants will attend regular visits during the course of the study at a hospital or clinic.
1,928 studies on the registry are indexed under Psoriasis; 234 are open to participants now.
This study's enrollment of 543 is above the median of 200 across 400 observational studies indexed under Psoriasis.
Browse Psoriasis studies →AbbVie is the lead sponsor of 969 studies on the registry; 134 are open to participants now.
Of its 357 completed or terminated interventional studies of FDA-regulated products, 214 (60%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adult participants with moderate-to-severe psoriasis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
- Participants with psychiatric conditions.
The draft CORONATE questionnaire will be administered to participants to create the final version of the questionnaire.
The questionnaire created in Phase 1 will be administered to a new group of participants for validation. All partners who are in a relationship with the participants since at least 3 years will be asked to participate in the study for the comparison between participants' and partners' perspectives on the impact of long-term psoriasis on participants' life.
CORONATE Questionnaire Score
The CORONATE Questionnaire is a self-administered 25 item questionnaire used to assess the long term effect of moderate to severe psoriasis. Scores range from 0 (false) to 3 (true).
Time frame: Up to 22 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.